Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2018-06-11
Purchase
Mirati Therapeutics, Inc.MRTXvenBio Select Advisor LLC
10% owner
400,000$38.85$15,540,000
2018-06-07
Purchase
Mirati Therapeutics, Inc.MRTXBoxer Capital, LLC
10% owner
193,050$38.85$7,499,992
2018-03-09
Sale
Mirati Therapeutics, Inc.MRTXDonadio Jamie A
Sr. VP, CFO
12,100$35.00$423,500
2018-03-09
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Scientific Officer
22,000$33.00$726,000
2018-03-01
Sale
Mirati Therapeutics, Inc.MRTXDonadio Jamie A
Sr. VP, CFO
51,875$27.13$1,407,368
2018-02-23
Sale
Mirati Therapeutics, Inc.MRTXBAUM CHARLES M
President & CEO
51,810$28.03$1,452,234
2018-02-06
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Scientific Officer
23,000$30.00$690,000
2018-01-26
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Scientific Officer
12,500$26.11$326,375
2018-01-16
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Science Officer
10,814$27.00$291,978
2018-01-11
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Science Officer
14,725$22.99$338,527
2017-11-16
Purchase
Mirati Therapeutics, Inc.MRTXBoxer Capital, LLC
10% owner
400,000$13.00$5,200,000
2017-11-16
Purchase
Mirati Therapeutics, Inc.MRTXvenBio Select Advisor LLC
10% owner
650,000$13.00$8,450,000
2017-11-16
Sale
Mirati Therapeutics, Inc.MRTXBroadfin Healthcare Master Fund Ltd
10% owner
60,000$18.05$1,083,000
2017-11-16
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Science Officer
10,275$18.00$184,950
2017-11-02
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Science Officer
7,499$14.00$104,986
2017-10-04
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Science Officer
4,000$14.00$56,000
2017-09-21
Sale
Mirati Therapeutics, Inc.MRTXTuesday Thirteen Inc.
10% owner
1,000$10.65$10,650
2017-09-15
Sale
Mirati Therapeutics, Inc.MRTXChristensen Jamie
SVP, Chief Science Officer
770$12.00$9,240
2017-01-26
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
48,169$5.45$262,521
2017-01-25
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
30,600$5.42$165,852
2017-01-24
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
27,682$5.32$147,268
2017-01-23
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
19,251$5.27$101,452
2017-01-20
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
23,873$5.42$129,391
2017-01-19
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
21,085$5.48$115,545
2017-01-18
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
16,200$5.50$89,100
2017-01-06
Purchase
Mirati Therapeutics, Inc.MRTXBoxer Capital, LLC
10% owner
286,163$5.60$1,602,512
2017-01-06
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
581,870$5.60$3,258,472
2016-06-14
Purchase
Mirati Therapeutics, Inc.MRTXBAUM CHARLES M
PRESIDENT & CEO, Director
20,000$7.05$141,000
2016-06-09
Sale
Mirati Therapeutics, Inc.MRTXBAKER BROS. ADVISORS LP
10% owner
545,058$9.45$5,150,798
2016-06-08
Sale
Mirati Therapeutics, Inc.MRTXBAKER BROS. ADVISORS LP
10% owner
158,100$9.21$1,456,101
2016-06-07
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
161,751$9.49$1,535,016
2016-06-07
Sale
Mirati Therapeutics, Inc.MRTXBAKER BROS. ADVISORS LP
10% owner
296,200$9.44$2,796,128
2016-06-06
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
215,151$10.31$2,218,206
2016-03-29
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
3,400$19.09$64,906
2016-03-28
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
300$19.48$5,844
2016-03-24
Purchase
Mirati Therapeutics, Inc.MRTXBraslyn Ltd.
10% owner
20,548$19.36$397,809

1 2 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*